• 8-Hydroxy-2'-deoxyguanosine protein immunoexpression is associated with the pathogenesis of actinic cheilitis
• 8-Hydroxy-2'-deoxyguanosine protein immunoexpression is associated with the pathogenesis of actinic cheilitis - Replay
• A Review of the Dermatologic Clinical Applications of Topical Photodynamic Therapy
• ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA
• Actinic Cheilitis
• Actinic Cheilitis
• Actinic cheilitis or squamous cell carcinoma of the lip? Practical recommendations on how to avoid a trap
• Actinic conjunctivitis and its relationship with prurigo in an indigenous population from the Highlands of Chiapas, Mexico
• Actinic Prurigo
• Angular Chelitis
• Aspects related to the inference of causality in cross-sectional studies. Comments on: "8-Hydroxy-2'-deoxyguanosine protein immunoexpression is associated with the pathogenesis of actinic cheilitis"
• Assessment of the association of myofibroblasts and structural components of the extracellular matrix with histopathological parameters of actinic cheilitis and lower lip squamous cell carcinoma
• Cheilitis: A Diagnostic Algorithm and Review of Underlying Etiologies
• CLINICAL EFFICACY OF PHOTODYNAMIC THERAPY IN MANAGEMENT OF ORAL POTENTIALLY MALIGNANT DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS
• Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis
• Clinicopathological Analysis of Actinic Cheilitis: A Systematic Review with Meta-analyses
• Combination of CO₂ laser therapy and pulsed dye laser therapy for the treatment of actinic cheilitis
• Cutaneous granular cell tumor: A case series, review, and update
• Dermoscopic Evaluation of Actinic Changes in the Lips of Indigenous Children Living at High Altitude in Ecuador: A Descriptive Study
• Dermoscopy to differentiate clinically similar inflammatory and neoplastic skin lesions
• Effects of Blue Light on the Skin and Its Therapeutic Uses: Photodynamic Therapy and Beyond
• Efficacy and safety of a 0.05 % nanoencapsulated imiquimod hydrogel for the treatment of actinic cheilitis: Drug release analysis and clinical study
• Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery
• Exposure to Atmospheric Ozone Disruption and Altitude Over 3500 m.a.s.l. are Associated with a Higher Prevalence of Photodermatoses in Pediatric Population of High-Altitude in Peru
• Increased prevalence of oral potentially malignant lesions among Croatian War invalids, a cross-sectional study
• Knowledge, Practice, and Awareness of Oral Cancer and HPV Infection among Dental Students and Residents: A Cross-Sectional Study
• Laminin Immunostaining in Biopsies as a Useful Biomarker of Early Invasion in Actinic Cheilitis and Differential Diagnosis Between Actinic Cheilitis and Lip Cancer: New Insights
• Lichen Planus of the Lip-Case Series and Review of the Literature
• Malignant Transformation of Actinic Cheilitis: A Decade-long Retrospective Study in Southern Brazil
• Multiple noninvasive auxiliary tests-assisted photodynamic therapy in actinic cheilitis: A case report
• Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis
• Possible role of ALDH1 and CD44 in lip carcinogenesis
• Prevalence of Oral Submucous Fibrosis With Other Oral Potentially Malignant Disorders: A Clinical Retrospective Study
• Radiofrequency therapy as an effective treatment for granulomatous cheilitis: A CARE case report
• Randomized Clinical Trial of Conventional versus Indoor Daylight Photodynamic Therapy for Treatment of Actinic Cheilitis
• Revisiting the evidence of photodynamic therapy for oral potentially malignant disorders and oral squamous cell carcinoma: An overview of systematic reviews
• S2k guideline: Laser therapy of the skin
• S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention
• S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures
• S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen: S3 guideline "actinic ke
• The scientometric characteristics of cheilitis researched by multidisciplinary specialists: A comparative study
• Transition to Medicare Does Not Contribute to Rise in Outpatient Visits for Nonmelanoma Skin Cancer, Actinic Keratosis, or Actinic Cheilitis in the US Population
• Treatment of Oral Dysplasia